Lecturio Medical
5 minutes
Regulation of purine de novo synthesis is governed by feedback inhibition, in which downstream nucleotide products (AMP, GMP) inhibit the enzymes catalyzing earlier and branch-point reactions to maintain balanced production of adenine and guanine nucleotides. This concept belongs to biochemistry/metabolic regulation, specifically nucleotide metabolism, and illustrates the general principle that a pathway's committed and branch-point enzymes serve as control points sensitive to end-product concentrations and cellular energy status. Improper balance between the two nucleotide pools is linked to mutation, underscoring the regulation's role in maintaining genomic fidelity during nucleic acid synthesis.